Le Lézard
Classified in: Health, Science and technology, Business
Subjects: TDS, BFA

Bisnow Announces Premier Two-Day Commercial Real Estate-Focused International Life Sciences & Biotech Conference


PHILADELPHIA, April 18, 2023 /PRNewswire/ -- Bisnow, the leading commercial real estate (CRE) news and events platform, is pleased to announce its first International Life Sciences & Biotech Conference, taking place October 11-12, at the Pennsylvania Convention Center in Philadelphia, PA. The two-day event will bring together industry leaders and innovators to discuss the latest trends and developments in the life sciences sector.

The two-day program features keynote presentations by leading figures in the life sciences industry, including executives from major pharmaceutical and biotech companies, academic researchers, and venture capitalists discussing:

The initial lineup includes C-suite speakers from Longfellow, Regeneron Pharmaceuticals, Breakthrough Properties, King Street Properties, Brandywine Realty Trust, and more to come.

"We've been putting on huge life sciences events around the globe for years now with sold-out crowds from London to Boston. This event will take the insights, networking and dealmaking that we've seen at our local market events and take it to the next level," said Bisnow CEO Gregg Mayer. "I'm thrilled to announce this one-of-a-kind conference and cannot wait to see the hundreds of executives across real estate and biotech come together in October."

The event will provide a forum to engage with prominent leaders across life sciences investment, development, research, design and the next wave of incubators. Attendees will gain knowledge of the latest developments in the sector, participate in top-tier networking and experience unmatched dealmaking opportunities.

Current sponsors include CRB Group, SmartLabs, Plymouth Group, Clean Space, Paradigm Structural Engineers, KSS Architects, SageGlass, Sterling Bay, HOK, JB&B, Mispro, HDR, DPR Construction, SGA, GMH Communities, Vicinity Energy, PCI, ShawContract, Neoscape and Lendlease.

To view the event and buy tickets, click here. For speaking or sponsorship opportunities, click here.

About Bisnow

Bisnow is the world's leading B2B platform serving the commercial real estate industry. From events and news to branded content and recruiting solutions, Bisnow reaches more than 11 million readers and hosts more than 450 events each year. Operating in over 50 local markets across the U.S., Canada, the UK and Ireland, our products inform and connect the commercial real estate industry to do more business.

CONTACT: Catherine White, 202-293-0370, [email protected]

SOURCE Bisnow


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: